BRCA1-associated cancers, including hereditary breast cancers due to germline mutations and sporadic breast cancers associated with promoter hypermethylation, have reduced or complete loss of expression of BRCA1 protein, and are frequently accompanied by mutations in TP53 [2,8,32,33]. This evidence concerns the gene TP53 and breast carcinoma.